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In Vivo Multimodal Magnetic 
resonance imaging changes  
after N-Methyl-d-aspartate-
Triggered spasms in infant rats
Minyoung Lee1,2, Mi-Sun Yum1,2*, Dong-Cheol Woo2, Woo-Hyun Shim2,3,  
Tae-Sung Ko1 and Libor Velíšek4,5,6
1 Department of Pediatrics, University of Ulsan College of Medicine, Ulsan, South Korea, 2 Asan Institute for Life Sciences, 
Asan Medical Center, Seoul, South Korea, 3 Department of Radiology, University of Ulsan College of Medicine, Ulsan, South 
Korea, 4 Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United States, 5 Department of 
Pediatrics, New York Medical College, Valhalla, NY, United States, 6 Department of Neurology, New York Medical College, 
Valhalla, NY, United States
Objective: Despite the serious neurodevelopmental sequelae of epileptic encepha-
lopathy during infancy, the pathomechanisms involved remain unclear. To find potential 
biomarkers that can reflect the pathogenesis of epileptic encephalopathy, we explored 
the neurometabolic and microstructural sequelae after infantile spasms using a rat model 
of infantile spasms and in vivo magnetic resonance imaging techniques.
Methods: Rats prenatally exposed to betamethasone were subjected to three rounds 
of intraperitoneal N-methyl-d-aspartate (NMDA) triggering of spasms or received saline 
injections (controls) on postnatal days (P) 12, 13, and 15. Chemical exchange saturation 
transfer imaging of glutamate (GluCEST) were performed at P15 and 22 and diffusion 
tensor imaging and additional spectroscopy (1H-MRI/MRS) of the cingulate cortex were 
serially done at P16, 23, and 30 and analyzed. Pathological analysis and western blotting 
were performed with rats sacrificed on P35.
results: Within 24 h of the three rounds of NMDA-induced spasms, there was an acute 
increase in the GluCEST (%) in the cortex, hippocampus, and striatum. When focused on 
the cingulate cortex, mean diffusivity (MD) was significantly decreased during the acute 
period after multiple spasms with an increase in γ-aminobutyric acid (GABA), glutamate, 
and glutamine N-acetylaspartate-plus-N-acetylaspartylglutamate (tNAA), total choline, 
and total creatine. The juvenile rats also showed decreased MD on diffusion tensor imag-
ing and significant decreases in taurine, tNAA, and macromolecules-plus-lipids in the 
cingulate cortex. Pathologically, there was a significant reduction in glial fibrillary acidic 
protein, myelin basic protein, and neuronal nuclei expression in the cingulate cortex of 
rats with NMDA-induced spasms.
significance: These neurometabolic and microstructural alterations after NMDA-
triggered spasms might be potential imaging biomarkers of epileptic encephalopathy.
Keywords: infantile spasms, Mr spectroscopy, neurometabolites, cingulate cortex, animal models
Figure 1 | Timeline of N-methyl-d-aspartate (NMDA)-induced spasms, MRI acquisition, behavioral tests, and tissue collection. IHC, immunohistochemistry;  
WB, western blot.
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inTrODucTiOn
Infantile spasms are an epileptic encephalopathy that requires 
urgent therapeutic intervention to avoid severe consequences, 
such as mental retardation and developmental regression (1). 
Diverse etiologies, including both unidentified causes and esta­
blished brain pathologies, can lead to infantile spasms with diffuse 
electrographic abnormalities (2), which probably impair common 
developmental processes such as synaptogenesis, myelination, 
and neuronal migration, causing mental retardation or refractory 
epilepsies in later life (3, 4). However, these neurodevelopmen tal 
consequences have not been clearly characterized (2).
To support the rationale for an aggressive treatment approach 
for infantile spasms, it is crucial to determine the changes pro­
duced by the spasms in the immature brain and assess the pos­
sibility for a restoration or reversal of these changes. In children 
with infantile spasms, evaluation of the effects of spasms on the 
brain is extremely complicated because of ethical problems and 
a relatively small number of patients with heterogeneous etiolo­
gies (5) and treatment protocols (6, 7).
From the bench side, it would be advantageous to have a model 
without pre­existing lesions and a model with easily operable 
spasms to identify the pathological effects of the experimental 
spasms on the brain. The rat model of N­methyl­d­aspartate 
(NMDA)­triggered spasms (4) after prenatal betamethasone pri­
ming is regarded as having a cryptogenic etiology and the spasms 
are reliably triggered by the injection of NMDA. The NMDA­
triggered spasms can be provoked at postnatal day 12–15, a 
period in rodents relevant to human infancy (3, 4). The model 
also displays several behavioral changes after multiple spasms (3), 
corresponding to those of patients with infantile spasms, and has 
recently been independently verified (8).
In the present study, using this rat model of NMDA­induced 
infantile spasms, we performed MR imaging to evaluate the 
acute and chronic neurometabolic and microstructural changes 
after spasms as potential biomarkers of epileptic encephalopathy. 
To add longitudinal in vivo data to this model, we adopted the 
latest high­field proton MRI technologies including chemical 
exchange saturation transfer imaging of glutamate (GluCEST), 
diffusion tensor imaging, and spectroscopy (1H­MRI/MRS). 
GluCEST imaging can map the level of glutamate in vivo at a high 
spatial resolution (9–11), and diffusion tensor imaging is used 
to reveal the in vivo connectivity of the nervous system (12, 13). 
1H­MRS allows noninvasive quantification of brain metabolites 
in specific brain areas and has been successfully used in the field 
of epilepsy research (14, 15). Specifically, the in vivo developmen­
tal changes in neurometabolites and connectivity were measured 
in the cingulate cortex, which has extensive connections with 
critical regions such as the basal ganglia, thalamus, brainstem, 
and hippocampus (16, 17). Additional histopathologic analyses 
and behavioral tests were performed to further elucidate the 
microstructural and neurochemical changes.
MaTerials anD MeThODs
animals
Experiments were approved by the Institutional Animal Care 
and Use Committee of the Ulsan University College of Medi­
cine and conformed to the Revised Guide for the Care and 
Use of Laboratory Animals [NIH GUIDE, 25(28), 1996] (18). 
Timed­pregnant Sprague­Dawley rats were purchased from an 
approved source (Orient Bio Inc., Seoul, Korea). The rats were 
housed individually in the animal facility during the remainder 
of their pregnancy with free access to standard rat chow and 
water on a regular 12­h light­dark cycle with the lights on at 
08:00. On gestational day 15, pregnant rats received two injections of 
0.4 mg/kg betamethasone (Sigma­Aldrich, St. Louis, MO, USA) 
at 08:30 and 18:30. Delivery occurred consistently on gestational 
day 22, which was considered postnatal day (P) 0 for the offspring.
Spasms were triggered by intraperitoneal injection of NMDA 
on P12 (6 mg/kg), P13 (10 mg/kg), and P15 (15 mg/kg); control 
groups received the same volume of saline (Figure 1). Imme diately 
3Lee et al. NMR Imaging in Infantile Spasms
Frontiers in Neurology | www.frontiersin.org April 2018 | Volume 9 | Article 248
after NMDA administration, the rats were observed for 90 min 
and only the animals confirmed to have had three bouts of spasms 
at the appropriate time points on each day (i.e., on P12, P13, 
and P15) were included in the analyses (4).
Mr imaging studies
Animals were maintained under anesthesia with 1% isoflurane 
in a 1:2 mixture of O2:N2O with monitoring of their respiratory 
rate, electrocardiogram, and rectal temperature. GluCEST MR 
imaging was performed using a 7.0 T/160­mm small­animal 
imaging system (Bruker Pharmascan, Ettlingen, Germany) with 
a single­channel surface coil. Images were obtained using a 9.4 
T/160­mm bore animal MRI system (Agilent Technologies, 
Santa Clara, CA, USA) for 1H­MRS and diffusion tensor ima­
ging. Radiofrequency excitation and signal detection were 
accomplished with a 72­mm quadrature volume coil and a two­
channel phased­array coil, respectively. Axial slices correspond­
ing to coronal images in the neuroanatomic axis were collected 
from the cervical spinal cord to the olfactory bulb.
GluCEST images were acquired from an axial slice (1­mm 
thick) that included the hippocampal region. GluCEST images 
were acquired using T2­weighted imaging (rapid acquisition 
with relaxation enhancement [RARE]) with a frequency selective 
saturation preparation pulse comprised a Gaussian pulse with 
a total duration of 1,000 ms (irradiation offset of 500.0 Hz and 
interpulse delay of 10 µs) at a B1 peak of 5.6 µT. Z­spectra were 
obtained from −5.0 ppm to +5.0 ppm with intervals of 0.33 ppm 
(total, 31 images, Figure S1 in Supplementary Material). The 
sequence parameters were as follows: repetition time/echo time 
(TR/TE) = 4,200/36.4 ms, field of view = 30 mm × 30 mm, slice 
thickness =  1  mm, matrix size =  96 ×  96, RARE factor =  16, 
echo spacing = 6.066 ms, and average = 1. To confirm the linear 
GluCEST effect, a phantom consisting of test tubes with different 
concentrations of glutamate (pH 7.0) images at 7 T was also done 
(Figure S2 in Supplementary Material).
To measure the GluCEST value (%), each region of interest 
(cortex, hippocampus, striatum) was drawn manually on the T2­
weighted anatomical MR images without a frequency selective 
saturation preparation pulse, and the regions of interest were 
overlaid on the GluCEST maps. GluCEST contrast is measured 
as the asymmetry between an image obtained with saturation at 
the resonant frequency of exchangeable amine protons (+3 ppm 
downfield from water for glutamate) and an image with satura­
tion equidistant upfield from water (–3 ppm), according to the 
following equation:
 
GluCEST(%) = − +
−
S S
S
−3 0 3 0
3 0
100. .
.
*
 ppm  ppm
 ppm  
where S−3.0ppm and S+3.0ppm are the magnetizations obtained with 
saturation at a specified offset from the water resonance of 
4.7 ppm.
The B0/B1 maps on the same slices were acquired for B0 and 
B1 correction. The B0 map was calculated by linearly fitting the 
accumulated phase per pixel following phase unwrapping against 
the echo time differences from gradient echo images collected 
at TEs of =1.9 and 2.6 ms. B1 maps were calculated by using the 
double­angle method (flip angles 30° and 60°) and the linear 
correction for B1 was calculated as the ratio of the actual B1 to the 
expected value.
1H­MRI/MRS images were obtained at the assigned times 
as follows (Figure 1): (1) 1 day after the last cluster of spasms 
(P16), (2) about 1 week after the spasms (P23), and (3) about 
2 weeks after the spasms (P30). The MR spectra were acquired 
through a signal voxel (from bregma to −3.0 mm in a coronal 
section, 3 mm × 2 mm × 1.5 mm) in the cingulate cortex using a 
point­resolved spectroscopy (PRESS) sequence for 128 acquisi­
tions with TR/TE = 5,000/13.4 ms. For quantification, unsup­
pressed water signals were also acquired from the same voxel 
(average = 8). All the MR spectra were processed with the linear 
combination analysis method (LC Model ver. 6.0, Los Angeles, 
CA, USA) to calculate the metabolite concentrations from a fit to 
the experimental spectrum, based on a simulated basis set. The 
following brain metabolites were included in the metabolite basis 
set: alanine (Ala), aspartate (Asp), creatine (Cr), γ­aminobutyric 
acid (GABA), glucose (Glc), glutamate (Glu), glutamine (Gln), 
glycerophosphorylcholine (GPC), phosphorylcholine (PCh), 
myo­inositol (mIns), lactate (Lac), phosphocreatine (PCr), 
N­acetylaspartate (NAA), N­acetylaspartylglutamate (NAAG), 
taurine (Tau), macromolecules (MMs), and lipids (Lip). The 
water­suppressed time domain data were analyzed between 
0.2 and 4.0 ppm, without further T1 or T2 correction. Absolute 
metabolite concentrations (mmol/kg wet weight) were calculated 
using the unsuppressed water signal as an internal reference 
(assuming 80% brain water content) (19). The in  vivo proton 
spectra were judged to have an acceptable value if the stand­
ard deviation of the fit for the metabolite was less than 20% 
(Cramer–Rao lower bounds). MR diffusion tensor images were 
acquired using a four­shot DT­echo planar imaging sequence 
(TR = 3.7 s, TE = 20 ms, B0 = 1,000 s/mm2) with a 10­ms inter­
val (Δ) between the application of diffusion gradient pulses, a 
4­ms diffusion gradient duration (δ), a gradient amplitude (G) 
of 46.52 mT/m, and the Jones 30 gradient scheme.
Postprocessing analysis was performed using Diffusion Toolkit 
software (http://trackvis.org/). The cingulate cortex of each rat 
was selected and the fractional anisotropy (FA) and mean diffu­
sivity (MD) were calculated from the diffusion tensor parametric 
maps. Subsequently, repeated measures ANOVA and t­tests were 
conducted to test for the treatment effect of the different diffusion 
parameters.
Behavioral Testing
After NMDA­induced spasms, rats performed an open­field 
test on P19 and fear conditioning tests on P27–29 (Figure  1). 
Behavioral experiments were conducted in a standard behavioral 
testing room during the light phase (08:00–20:00 h) of a regular 
12­h light–dark cycle.
Open-Field Test
The locomotive activity of controls and rats after NMDA­
triggered spasms was assessed using an open­field test as previ­
ously described (20). Rats were placed into a black plastic box 
(60 cm × 60 cm2 field with a 30­cm high perimeter) for 5 min, 
and their activities were monitored (3, 21) using computerized 
motion­tracking software (SMART 3.0; Panlab S.L.U., Barcelona, 
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Spain). The center was defined as the middle area 10 cm apart 
from each wall and the other area was defined as the periphery 
(i.e., 2,000 cm2 periphery and 1,600 cm2 center; allocation of the 
area = 5:4).
Fear conditioning
The observation chamber (25 cm × 25 cm × 25 cm; Panlab S.L.U.) 
was constructed of aluminum (two side walls and ceiling) and 
Plexiglas (rear wall and hinged front door) and was situated in a 
soundproof box. The floor of the chamber consisted of 19 stainless 
steel rods (4 mm diameter) spaced 1.6 cm apart (center to center), 
which were connected to a shock generator and grid scrambler 
(Panlab S.L.U.). A tone (conditioned stimulus) was delivered by 
a speaker mounted on one side panel of the chamber and both 
the shock and tone deliveries were controlled by a computerized 
system.
Tone conditioning was conducted on P27. Modified from 
a previous report (22), the conditioning consisted of a 3­min 
baseline habituation in the experimental chambers, followed by 
exposure to five pairings of a tone (conditioned stimulus; 30 s, 
85  dB, 2,000  Hz) with white­light illumination, each ending 
with a final footshock (unconditioned stimulus; 0.8 mA, 2.0 s) 
followed by a 20­s silent interval. Response to the context was 
monitored on P28 (24 h after the conditioning trial). The rats 
were returned to the chamber for 5 min, and freezing behavior 
was measured in response to the context. Fear response to the 
conditioned stimulus was conducted at 24 h after the contextual 
fear testing (P29). To reduce the influence of context on cued 
fear conditioning, tactile and visual cues were manipulated with 
the replacement of a wall and a floor. Following a 2­min period 
without a conditioned stimulus (first session, unconditioned), 
the rats were presented with five tone parings (85  dB, 2  kHz, 
30 s, session Nos. 2, 4, 6, 8, and 10; 20 s between tone presenta­
tions, session Nos. 3, 5, 7, 9, and 11) without any foot shock. 
The behaviors of the rats were recorded and analyzed using the 
signal generated by a high­sensitivity weight transducer system 
(Panlab S.L.U.).
sample Preparation and 
immunohistochemistry
The animals with three bouts of spasms on P12, P13, and P15 and 
the corresponding controls were transcardially perfused with 
4% paraformaldehyde on P35 under deep anesthesia, and their 
brains were removed and cryoprotected. Twenty­micron serial 
coronal sections were cut on a cryocut microtome.
For immunohistochemistry, myelin basic protein (MBP) anti­
body (1:1,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, 
USA), glial fibrillary acidic protein (GFAP) antibody (1:2,000; 
EMD Millipore, Billerica, MA, USA), or neuronal nuclei (NeuN) 
antibody (1:2,000; EMD Millipore) were used as primary anti­
bodies. All slides were examined by light microscopy (Olympus 
BX­53; Olympus Co., Tokyo, Japan). Semi­quantification analysis 
of immunohistochemical staining was performed using ImageJ 
(NIH, Bethesda, MD). The corresponding area in the cingulate 
cortex cg2 subfield was analyzed to determine the NeuN­ and 
GFAP­positive cell count and the stained area measurement of 
MBP. Three or five randomly selected areas (1.0 × 104 sq μm) on 
each section were used for NeuN­ and GFAP­positive cell count­
ing. The same areas of binarized images of MBP­stained sections 
were quantified from each animal.
Western Blot analysis
After deep anesthesia, bilateral cortical tissues from bregma to 
the posterior hippocampal area without the hippocampus (ante­
rior posterior 0 to −5  mm) were collected from controls and 
rats with NMDA­triggered spasms on P35. Anti­MBP (1:2,000; 
Santa Cruz Biotechnology, Inc.), anti­NeuN (1:5,000; EMD 
Millipore), or anti­GFAP (1:5,000; EMD Millipore) antibodies 
were used. Normalization was performed by the development of 
parallel western blots probed with β­actin (1:20,000; Santa Cruz 
Biotechnology Inc.) antibody analyzed by densitometry using 
ImageJ software (NIH, Bethesda, MD).
statistics
The Mann–Whitney’s U test was used for the comparison of 
two groups and Student’s t­test was used for the data following 
normal distribution. The concentrations of metabolites were 
compared between the groups and time points using a linear 
mixed model. The absence of significant sex­based differences 
(p always > 0.10) was confirmed in advance, and both sexes were 
combined. The significance level was preset to p < 0.05. Statistical 
analyses were conducted using SAS® Version 9.3 (SAS Institute 
Inc., Cary, NC, USA) and SPSS 18.0 (IBM Corp., Armonk, 
NY, USA).
resulTs
Mapping of the glutamate concentration 
at acute Periods after Three rounds  
of nMDa spasms
There were significant increases in the GluCEST (%) levels of rats 
with three rounds of NMDA­induced spasms in the cortex and 
hippocampus at P15 (N = 14; cortex, 13.20 ± 0.74%, p = 0.011; 
hippocampus, 12.36 ± 0.91%, p = 0.016; striatum, 10.10 ± 0.96%, 
p  =  0.062) compared with controls (N  =  14, 9.71  ±  0.82%, 
9.32 ± 0.81%, 7.23 ± 1.00% in each area). There was a develop­
mental increase in the GluCEST (%) at P22 but no significant 
difference in the GluCEST (%) between the rats with spasms and 
controls (Figure 2).
neurochemical alterations in the 
cingulate cortex after Multiple  
nMDa-Triggered spasms
There was no significant morphological difference between the two 
groups (NMDA­induced spasms [n = 12] and controls [n = 10]) 
on visual evaluation of serial T2­weighted MR images. One day 
after the last NMDA injection (P16), GABA (p =  0.008), Glx 
(Glu + Gln, p = 0.024), tNAA (p = 0.006), tCho (p = 0.014), 
and tCr (p  =  0.007) levels measured from cingulate cortex 
(Figure 3A) were significantly increased in rats with NMDA­
induced spasms (Figures 3B,E,G,H). At 1 week (P23) after the 
Figure 2 | (a) After three rounds of spasms on postnatal day (P) 12, 13, 
and 15, glutamate chemical exchange saturation transfer (GluCEST, %) levels 
were measured in the cortex, hippocampus, and striatum on P15. (B) There 
were significant increases in the GluCEST (%) of rats with three rounds of 
N-methyl-d-aspartate (NMDA)-induced spasms compared with controls in  
all measured areas. A developmental increase in the GluCEST (%) from P15 
to P22 was noted, and there was no significant difference in the GluCEST  
(%) between rats with spasms and controls.
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NMDA­induced spasms, there were also no significant differ­
ences in the concentrations of the neurochemicals measured 
in the cingulate cortex between the two groups. At 2  weeks 
(P30) after the NMDA­induced spasms, Tau (p = 0.016), tNAA 
(p =  0.026), and MM +  Lips (p =  0.042) were significantly 
decreased compared with controls (P30; Figures  3D–F). The 
temporal changes in each neurometabolite were compared 
between the groups, and glutamine and glutamate (Glx, 
F =  3.30, DF1 =  2, DF2 =  34.7, p =  0.049), Tau (F =  10.52, 
DF1 = 2, DF2 = 32.5, p < 0.001), tNAA (NAA + NAAG, F = 6.57, 
DF1 = 2, DF2 = 15.7, p = 0.008), MMs and lipids (MM + Lips, 
F = 4.01, DF1 = 2, DF2 = 15.4, p = 0.039), and total choline 
(tCho, p = 0.006) were significantly different between the two 
groups (Figures 3C–G).
in Vivo Microstructural alterations 
Following Multiple Bouts of nMDa-
Triggered spasms
There was no significant difference in the FA values at each time 
point between rats with spasms (N = 15) and controls (N = 15). 
The rats with multiple bouts of NMDA­triggered spasms showed 
a significantly decreased MD at P16 and P30 in both cingulate 
cortices (right/left cingulate cortex: P16, 6.64 × 10−4/6.59 × 10−4, 
p = 0.012/p = 0.001; P30, 6.05 × 10−4/6.14 × 10−4; p = 0.036/p = 0.016) 
compared with controls (P16, 7.01  ×  10−4/7.06  ×  10−4; P30, 
6.48 × 10−4/6.74 × 10−4, Figure 4).
Behavioral changes after Multiple  
Bouts of nMDa-Triggered spasms
To evaluate the behavioral changes that occurred after multiple 
bouts of NMDA­induced spasms, the results of open­field and 
fear conditioning tests were compared between the rats that 
had experienced three bouts of NMDA­triggered spasms and 
controls. In the open­field test on P19, the rats with NMDA­
induced spasms (n = 23) traveled a significantly shorter distance 
through the peripheral area (p = 0.005) as well as in the total area 
(p = 0.006) compared with controls (n = 20; Figure 5A). Resting 
time in the peripheral area was significantly increased in rats with 
NMDA­induced spasms (p = 0.012) compared with controls. The 
time spent in slow and fast motion in the peripheral area was 
significantly decreased in the rats with NMDA­induced spasms 
compared with controls (p = 0.014 and p = 0.010, respectively; 
Figure 5B). The time spent in the center was equivalent in the 
two groups.
In fear conditioning tests on P27–29, there was no difference in 
tone conditioning on P27 or response to context on P28. However, 
on P29, the total freezing durations were significantly increased 
in rats with NMDA­induced spasms compared with controls 
(p = 0.037; Figure 5C). During the first session, freezing durations 
were not different between the two groups (p = 0.058), but freez­
ing durations were significantly increased in rats with NMDA­
induced spasms at conditioned sessions from 6 to 9, in particu lar 
(p = 0.007, 0.002, 0.047, and 0.022, respectively; Figure 5D).
reduced gFaP, MBP, and neun 
expression in the Juvenile Period  
after Multiple Bouts of nMDa- 
Triggered spasms
Semi­quantitative analysis of immunohistochemical staining on 
P35 revealed a significant reduction in NeuN­ and GFAP­positive 
cells (both p < 0.001) and MBP­positive area (p = 0.041) in rats 
with three bouts of NMDA­triggered spasms (on P12, P13, and 
P15, n = 13) compared with controls (n = 11) (Figure 6). The 
cortical protein expression levels of GFAP, MBP, and NeuN on 
P35 were quantified and compared between the rats with multiple 
spasms and controls. GFAP (p = 0.007), MBP (p = 0.027), and 
NeuN (p =  0.001) expression was significantly reduced in the 
cortex of rats with NMDA­induced spasms (n = 13) compared 
with controls (n = 13; Figure 6).
DiscussiOn
An early diagnosis of infantile spasms has been considered criti­
cal for improving the neurodevelopmental outcomes of affected 
patients (23). However, it is uncertain which part of the developing 
brain is affected by infantile spasms, as is the extent of any brain 
insult and whether it is reversible. Our present study focused on 
metabolic and microstructural brain insults after spasms in a rat 
model of infantile spasms using in vivo MR imaging. Behavioral 
tests and ex vivo histopathological processes were employed to 
support the results.
Considering the increased metabolism of brain tissue dur­
ing seizures, neurochemical dysfunction might be the main 
Figure 3 | Neurochemical changes in rats with N-methyl-d-aspartate (NMDA)-induced spasms using 1H-MRS findings. (a) A single voxel position in the cingulate 
cortex (top, coronal section; bottom, horizontal section). The brain levels of GABA, glutamine + glutamate (Glx), tNAA, total choline, and tCr were significantly  
higher in rats with NMDA-induced spasms on P16 (B,c,e,g,h). (D–F) At 2 weeks, taurine (Tau), tNAA, and macromolecules + lipids (MM + lipids) were significantly 
decreased in rats with spasms. (c–g) The changes in Glx, Tau, tNAA, MM + lipids, and total choline with time were significantly different between the groups.  
(i) The examples of MR spectra from rats with or without 3 NMDA spasms on each time points, P16 and P30 clearly shows the neurometabolic changes after 
NMDA-induced spasms. *indicates a significant difference between the groups at each time point (p < 0.05). Using a generalized linear mixed model, there were 
also significantly different interactions between the groups and time points for Glx, Tau, tNAA, MM + lipids, and total choline (each p-value is marked on the graph). 
All imaging was done on the same timepoints (P16, 23, and 30), although the data points are not aligned across groups to avoid overlapping of the two graphs.
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Figure 4 | (a) On diffusion tensor imaging of rats after N-methyl-d-aspartate (NMDA)-induced spasms and controls, fractional anisotropy (FA) and mean diffusivity 
(MD) were measured in the cingulate cortex of each animal. (B) The anatomical location of cingulate cortex was clearly identified on FA/MD maps of the rat at P16. 
(c) There were no significant differences in the FA values at each time point between the rats with spasms (N = 15) and controls (N = 15). Rats with multiple bouts 
of NMDA-triggered spasms showed a significantly decreased MD at P16 and P30 in both cingulate cortices compared with controls.
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Figure 5 | Comparison of behavioral changes between rats with N-methyl-d-aspartate (NMDA)-induced spasms and controls. (a,B) Open-field test showing 
significantly decreased exploration distances in rats with NMDA-induced spasms in peripheral and total areas (a) and significantly increased resting activities and 
decreased slow and fast activities in the peripheral area (B) of rats with spasms. The rats with NMDA-induced spasms also showed significantly increased durations 
of freezing to sound and light stimuli (c) that persisted after several sessions without shocks (D) in a fear conditioning test. There was a significant difference in 
freezing durations between the two groups. *indicates a significant difference between the groups (*p < 0.05, Mann–Whitney U test).
8
Lee et al. NMR Imaging in Infantile Spasms
Frontiers in Neurology | www.frontiersin.org April 2018 | Volume 9 | Article 248
pathophysiologic feature of the epileptic brain (24), especially 
during the acute stage. The GluCEST technique quantifies gluta­
mate by measuring proton exchange between the amine protons 
of the glutamate and the water protons and the measurement 
is at least 100 times more sensitive than the traditional 1H 
MRS method (9, 25). The GluCEST is suggested as a surrogate 
marker of glutamate concentration in glial cells at the synaptic 
level (25) and glutamate contributes >90% of the GluCEST 
signal with <10% contribution from other metabolites in glial 
neuronal unit (10). Previous study with temporal lobe epilepsy 
patients also showed the high potential of GluCEST identifying 
the epileptogenic foci (26). Thus, we hypothesized that the area 
of hyperexcitation in rats with NMDA­induced spasms can be 
screened with GluCEST imaging with high spatial resolution 
during acute periods. GluCEST mapping showed significantly 
increased glutamate in cortex and hippocampus at P15 after 
multiple rounds of spasms (Figure 2), which suggests that the 
cortex is one of the major brain area of hyperexcitation by the 
NMDA­induced spasms.
Our in  vivo serial neurochemical/microstructural analysis 
focused on the cingulate cortex in the rat after multiple bouts 
of spasms. The cingulate cortex is a region of the limbic system 
reciprocally linked to the hippocampus (17) and with extensive 
connections to the critical regions for spasm generation, includ­
ing the basal ganglia, thalamus, and brainstem (16, 27). In the 
cingulate cortex, consistent with the findings of GluCEST imag­
ing, acute elevations in GABA, Glx, tNAA, tCho, and tCr were 
noted in rats after multiple bouts of NMDA­induced spasms 
compared with controls (Figure 3). The glutamate plus glutamine 
levels likely represent the neuronal metabolic pool. In vivo human 
proton MRS studies (28, 29) have also reported alterations in 
GABA and glutamate in patients with epilepsy. In addition, 
choline (Cho) represents a precursor for the neurotransmitter 
acetylcholine (30) and creatinine is associated with energy 
metabolism (31, 32). The early elevation of markers of neuronal 
metabolism together with the excitatory neurotransmitters in the 
cingulate cortex may also reflect activation of the cingulate cortex 
during NMDA­induced spasms in this model.
With diffusion tensor imaging, we also identified an acute 
decrease in MD in the cingulate cortex after three bouts of spasms, 
which represent the early brain damage (33). MD is an inverse 
measure of the membrane density, is sensitive to cellularity, 
edema, and necrosis (34). MD decrease quickly after injury (first 
day) in most models studied, which is consistent with our find­
ing at P16. The decrease was explained by the decrease in water 
diffusion associated with injury such as cellular edema, despite 
Figure 6 | Glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), and neuronal nuclei (NeuN) expression in the cingulate cortex during the juvenile period. 
(Left) Immunohistochemical staining of the cingulate cortex on P35 revealed decreased expression of GFAP, MBP, and NeuN in rats with three bouts of N-methyl-d-
aspartate (NMDA)-induced spasms. The scale bars indicate 50 µm. (Right) Western blot analysis of the rat cortex on P35 showed significantly decreased expression 
of GFAP, MBP, and NeuN after multiple bouts of NMDA-induced spasms (*p < 0.05, Mann–Whitney U test).
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there is still debate on the precise mechanism for the decrease in 
MD associated with injury. Previously postictal decrease of MD 
was reported in human (35), which is consistent with our finding 
and probably reflects neuronal swelling by excitotoxic injury in 
the brain areas involved in seizure.
In addition to these acute changes associated with spasms, 
in vivo MR imaging enables us to perform a longitudinal follow­
up of neurometabolic and microstructural alterations in rats 
with NMDA­triggered spasms. NMDA is an excitatory amino 
acid that can cause neuronal death and glial activation is well 
observed in kainic acid animal model and tissues of patients with 
chronic epilepsy (36). However, gross morphological changes 
caused by NMDA­induced spasms in our model were not 
evident on brain MR imaging and a previous pathologic report 
of NMDA­induced seizures in young animals also reported no 
gross morphological changes on pathology (37). Consistently 
with this finding, FA, a gross measure of microstructural integ­
rity marker that is less specific to the type of injury (33), is not 
affected in every time point of this study.
In the cingulate cortices of the juvenile rats with NMDA­
induced spasms (P30), tNAA, Tau, and MM +  lipids were sig­
nificantly decreased with a significant reduction in MD. We also 
found decreased expression of neuronal, astrocyte, and myelina­
tion markers after NMDA­induced spasms in these rats. These 
findings suggest the different mechanism of injury during infancy 
compared to that of the adulthood. Instead of cell death or gliosis 
after excitatory injury, the developmental process of their brain, 
active protein synthesis and cell proliferation, may be involved. 
These pathologic changes are also in line with a significant reduc­
tion in neuronal markers, NAA, and Tau and markers of myelin 
production and substructural components such as MMs and 
lipids (31, 38), as well as the reduced MD reflecting decreased 
membrane density and cellularity (34, 39).
Previous research into epilepsy has already shown the typi­
cal developmental pattern of neurometabolites in both a rodent 
model (40) and in humans (32). NMDA­triggered spasms signifi­
cantly impaired this time­dependent neurometabolic develop­
mental pattern of Glx, Tau, tNAA, MM + lipids, and total choline 
(Figure 3). These combined alterations in neurometabolites and 
structural maturation markers in this animal model indicate 
the compromised development of the cingulate cortex follow­
ing NMDA­triggered spasms. Also, the decrease of all proteins 
examined can be explained by a decrease in protein synthesis 
during the critical brain development after NMDA­triggered 
spasms.
Furthermore, decreased exploratory behaviors in the periph­
eral areas and increased freezing activities to conditioned sound 
and light stimuli were also observed in our study group that 
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suffered from NMDA­induced spasms. Other behavioral disrup­
tions were found in previous studies with similar models (21, 37). 
Considering the widespread reduction in neuronal metabolites 
in neurodevelopmental disorders (31) and a positive correlation 
between motor skill learning and myelination (41), the pathologi­
cal changes in the brain might explain these behavioral changes.
In conclusion, NMDA­induced spasms during infancy lead to 
time­dependent neurochemical and microstructural changes in 
the cingulate cortex and subsequent pathologic changes during 
the juvenile period. These age­dependent alterations in neuro­
metabolites after NMDA­triggered spasms should be further 
explored as potential biomarkers of outcomes in human infantile 
spasms or other epileptic encephalopathies.
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